+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Germany Clinical Trial Supplies Market Size and Forecast, by Phase, by Products & Services, by End-use, by Therapeutic Use, and Trend Analysis, 2014-2025

  • ID: 4659665
  • Report
  • September 2018
  • Region: Germany
  • 78 pages
  • Hexa Research
1 of 3

FEATURED COMPANIES

  • Almac Group
  • Biocair
  • Catalent, Inc.
  • KLIFO
  • Movianto
  • PCI Pharma Services
  • MORE
“Germany Clinical Trial Supplies Market Size and Forecast, by Phase (Phase I, Phase II, Phase III), by Products & Services, by End-use, by Therapeutic Use, and Trend Analysis, 2014-2025

Germany clinical trial supply market size is projected to reach USD 206.0 million by 2025, in terms of revenue. Growing number of clinical trial studies in Germany is expected to keep the market buoyant over the coming years. Increasing complexity of conducting trials is driving the competition in the industry as a large number of clinical supplies companies are investing millions in IT and cold chain facilities.

Growth in number of sites per study and changing study design of clinical trials along with increased number of new drug trials, which are tested against an approved marketed drug, are responsible for the growing complexity in clinical trials. Rising need for supply chain planning, software for inventory management, and ancillary supply chain management is also likely to contribute towards the growth of the Germany clinical trial supplies market.

According to the clinical trial logistics survey by Nice Insights, 35.0% of Phase III clinical trials are outsourced and it is anticipated to increase further on account of growing number of investigational drugs advancing to the next phase. This trend is expected to stimulate the demand for efficient supply chain and logistics, thereby contributing to the industry growth.

Germany clinical trial supplies market in oncology sector comprises primary, as well as secondary packaging. The objective of packaging is to better manage and improve patient compliance. Packaging must prevent gases from aerosolizing and protect vials from leakage. Packaging is completed in accordance to the dosage requirement. The metabolic disorders segment is predicted to grow on account of government funding for clinical trials.

For instance, according to the National Center for Biotechnology Information, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsored clinical trials for diabetes in 2016. The manufacturing activity at times is higher for post market drugs, thereby leading to rising demand for supplies. In addition, certain drugs, medical devices, and other healthcare products are mandated to undergo further testing by the FDA, which contributes to generation of revenue.

The number of products undergoing further testing and increasing stringency in management are fueling the industry growth. Major companies operating in this industry include The Almac Group; Biocair International Ltd.; Catalent, Inc.; KLIFO A/S; Movianto. Collaborations and acquisitions activities undertaken by the industry players are likely to increase the competition in the market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Almac Group
  • Biocair
  • Catalent, Inc.
  • KLIFO
  • Movianto
  • PCI Pharma Services
  • MORE
Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information procurement
2.2 Data Analysis

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market size and growth prospects
3.2.1 Market driver analysis
3.2.2 Market restraint analysis
3.3 Industry Analysis Porter’s
3.4 Germany clinical trial supplies PESTEL Analysis

Chapter 4 Germany Clinical Trial Supplies Market: Phase Estimates & Trend Analysis
4.1 Germany Clinical Trial Supplies Market: Phase Movement Analysis
4.2 Phase I
4.2.1 Phase I market, 2014 - 2025 (USD Million)
4.3 Phase II
4.3.1 Phase II market, 2014 - 2025 (USD Million)
4.4 Phase III
4.4.1 Phase III market, 2014 - 2025 (USD Million)
4.5 Others
4.5.1 Others market, 2014 - 2025 (USD Million)

Chapter 5 Germany Clinical Trial Supplies Market: Product/Service Estimates & Trend Analysis
5.1 Germany clinical trial supplies market: Product/Service movement analysis
5.2 Manufacturing
5.2.1 Manufacturing market, 2014 - 2025 (USD Million)
5.3 Storage & Distribution
5.3.1 Storage & distribution market, 2014 - 2025 (USD Million)
5.3.2 Cold Chain-based
5.3.2.1 Cold Chain-based storage & distribution market, 2014 - 2025 (USD Million)
5.3.3 Non-cold Chain-based
5.3.3.1 Non-cold chain based storage & distribution market, 2014 - 2025 (USD Million)
5.4 Supply Chain Management
5.4.1 Supply chain management market, 2014 - 2025 (USD Million)

Chapter 6 Germany Clinical Trial Supplies Market: End-use Estimates & Trend Analysis
6.1 Clinical Trials Market: End-use Movement Analysis
6.2 Pharmaceuticals
6.2.1 Pharmaceuticals market, 2014-2024 (USD Million)
6.3 Biologics
6.3.1 Biologics market, 2014 - 2025 (USD Million)
6.4 Medical device
6.4.1 Medical device market, 2014 - 2025 (USD Million)
6.5 Others
6.5.1 Other end-use market, 2014 - 2025 (USD Million)

Chapter 7 Germany Clinical Trial Supplies Market: Therapeutic Use Estimates & Trend Analysis
7.1 Clinical Trials Market: Therapeutic Use Movement Analysis
7.2 Oncology
7.2.1 Oncology market, 2014-2024 (USD Million)
7.3 Central Nervous System (CNS) disorders
7.3.1 CNS market, 2014 - 2025 (USD Million)
7.4 Cardiovascular diseases
7.4.1 Cardiovascular market, 2014 - 2025 (USD Million)
7.5 Infectious diseases
7.5.1 Infectious disease market, 2014 - 2025 (USD Million)
7.6 Metabolic syndromes
7.6.1 Metabolic disorders market, 2014 - 2025 (USD Million)
7.7 Others
7.7.1 Other therapeutic use market, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Almac Group
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Biocair
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 Catalent, Inc.
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 KLIFO
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.5 Movianto
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 PCI Pharma Services
8.6.1 Company overview
8.6.2 Financial Performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 PAREXEL International Corporation
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Sharp Packaging Services
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 Thermo Fisher Scientific Inc
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives

*List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3
  • Almac Group
  • Biocair
  • Catalent, Inc.
  • KLIFO
  • Movianto
  • PCI Pharma Services
  • PAREXEL International Corporation
  • Sharp Packaging Services
  • Thermo Fisher Scientific Inc
Note: Product cover images may vary from those shown
Adroll
adroll